Expert reviewed • 08 January 2025 • 4 minute read
Non-infectious disease management has shifted towards integrated, patient-centred strategies. Advances in technology, personalised medicine, and multidisciplinary care models reflect this evolution.
A 45-year-old with newly diagnosed Type 2 diabetes exemplifies comprehensive care. Continuous glucose monitoring provides real-time data, guiding medication adjustments and dietary management. Exercise programs and careful oversight of HbA1c levels ensure long-term control.
| Treatment Component | Implementation | Outcome Measure |
|---|---|---|
| Glucose Monitoring | Continuous monitoring system | Real-time data |
| Medication | Personalised drug therapy | HbA1c levels |
| Lifestyle | Structured program | Weight, activity |
Breast cancer treatment uses molecular profiling to select targeted therapies, improving efficacy and reducing side effects. Regular imaging and molecular markers guide timely treatment adjustments.
Modern cardiac care combines personalised medication, tailored exercise, dietary guidance, and stress reduction. These measures improve patient engagement and outcomes.
| Intervention | Traditional Approach | Modern Enhancement |
|---|---|---|
| Medication | Standard protocols | Genetic-guided therapy |
| Exercise | General advice | Individually tailored |
| Diet | Basic guidelines | Personalised planning |
Early aggressive treatment in rheumatoid arthritis uses advanced imaging and disease-modifying drugs. Regular monitoring adjusts therapy based on disease activity, improving quality of life.
Costs, access disparities, and patient compliance remain obstacles. Solutions include telemedicine for remote monitoring, digital tools for patient engagement, and tiered treatment options.
Technology integration (AI, digital health), patient engagement, and continuous monitoring shape the future. Personalised strategies and coordinated care models promise better outcomes and sustainability.